Eric S. Miller, MD
NPI 1134514201ActiveIndividual· Internal Medicine, Rheumatology· Oakdale, MN
Opted out of Medicare from June 2026 to June 2028. Internal Medicine, Rheumatology (MD) in Oakdale, Minnesota, licensed in MN and WI, with an NPI issued in April 2015. Their prescriptions cost Medicare Part D more than their services did: $735,361 for 963 claims, against $218,456 paid for services in 2024. Boehringer Ingelheim Pharmaceuticals, Inc. reported $124.97 in payments in 2025, mostly food and beverage.
Overview
| NPI | 1134514201 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Apr 5, 2015 |
| Last updated in NPPES | Jun 26, 2026 |
| Certified by provider | Jun 26, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Rheumatology Primary | 207RR0500X | 66705 | MN |
| Internal Medicine, Rheumatology | 207RR0500X | 72681-20 | WI |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Jun 27, 2026 – Jun 27, 2028 |
| Can order and refer | Yes |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 196 |
|---|---|
| Services billed | 15,798 across 74 procedure codes |
| Paid by Medicare | $218,456 |
Part D prescriptions in 2024
| Prescriptions (claims) | 963 · 2,173 30-day fills |
|---|---|
| Patients | 197 |
| Total drug cost | $735,361 |
| Generic share | 88% of claims |
Education and affiliations
| Graduation year | 2015 |
|---|---|
| Medicare specialty | Rheumatology |
| Secondary specialties | Internal Medicine |
Industry payments (Open Payments)
- 2025$124.97 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.97 | 1 |
What the 2025 payments were for
- Food and Beverage$124.97 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records